Mini-invasive Surgery微创外科
Mini-invasive Surgery(英文缩写 MINI-INVASIVE SURG),ISSN 2574-1225,eISSN 2574-1225,中文译名:微创外科 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-10-01 至 2026-09-30，按本站收录文献的发表日期统计。
期刊介绍
Mini-invasive Surgery 最新收录文献
-
1. Current controversies with active surveillance management of small renal masses.
PMID:日期:2026-05-12Active surveillance (AS) management for patients with small renal masses (SRMs) is increasing globally, but questions remain regarding optimal AS practice. This review provides an evidence-based perspective on current controversies in SRM AS management. Considerable variation in AS utilization likely reflects non-standardization of patient selection criteria and differences among providers and healthcare settings. While most expert-consensus guidelines still restrict AS candidacy to patients with very small (< 1-2cm) renal tumors or significant health issues, increasing research supports AS to be an acceptable option for tumors up to 4 cm and a preferred option for many tumors up to 2 cm. For younger patients, AS appears oncologically safe but efficacy for long-term avoidance of delayed intervention (DI) remains unknown. Progression definitions for triggering DI still lack standardization, but there is general consensus for including thresholds based on some or all "GLASS" criteria [Growth rate; Longest tumor diameter; Adverse biopsy histology; Stage (≥ cT3a); Symptomatology]. SRM biopsy during AS can diagnose benign neoplasm with high accuracy to negate the need for DI, particularly when corroborated by computed tomography (CT) enhancement-based approaches such as tumor:cortex Peak Early Enhancement Ratio (PEER) scoring. In contrast, the value for biopsy in adverse histology detection remains more controversial. Advanced imaging modalities, including 99mTc-sestamibi single photon emission computed tomography (SPECT)/CT and [Zr]Zr-girentuximab positron emission tomography (PET)/CT, may serve as useful adjuncts to biopsy during AS, while providing limited accuracy alone when biopsy is deferred. Future investigative efforts should focus on standardizing AS protocols, refining progression criteria for intervention, and addressing uncertainties about longer-term outcomes, particularly in younger patients.
-
2. Gastroesophageal reflux disease related to laparoscopic sleeve gastrectomy.
PMID:日期:2025-08-26Obesity remains a global public health burden. The most common surgical approach for this condition worldwide is laparoscopic sleeve gastrectomy (LSG). Although it is highly effective at achieving both short- and long-term weight loss, comparable to outcomes demonstrated by Roux-en-Y gastric bypass, there are growing concerns about the development or worsening of another prevalent and morbid condition, gastroesophageal reflux disease (GERD), following sleeve gastrectomy (SG). In this narrative review, we summarize current concerns related to GERD in the context of SG. We review the pathophysiologic mechanisms that predispose the SG anatomy to GERD, focus on the prevalence of and worsening GERD and its associated complications, Barrett's esophagus, review expert recommendations for GERD evaluation pre- and post-surgery, and discuss therapeutic options for those with severe GERD following SG.
-
3. Robotic-assisted minimally invasive esophagectomy: experience at the University of Pittsburgh Medical Center.
PMID:日期:2025-06-24Robotic-assisted minimally invasive esophagectomy (RAMIE) is increasingly used in the treatment of resectable esophageal cancer. This is a report on the current technique of RAMIE at University of Pittsburgh Medical Center (UPMC), including a summary of early data on 65 patient outcomes reported in an ongoing esophageal cancer database. To date, we have performed over 200 cases of RAMIE at UPMC from September 2013 to July 2024, and the analysis of the data will be presented soon. The practice has evolved into a near-total RAMIE experience for several surgeons, while others remain in a learning curve. It is our experience that the initial performance of RAMIE requires strong mentoring by an experienced robotic surgeon. However, at this time, we are unable to provide guidelines for specific case numbers to achieve proficiency. As more patients with esophageal cancer are treated with robotic-assisted minimally invasive esophagectomy (MIE) at UPMC, data have shown that patient outcomes are not compromised compared with that of traditional MIE. In fact, RAMIE may demonstrate superiority in the median number of lymph nodes harvested, which could contribute to increased accuracy in pathologic staging. This approach has developed a strong surgeon preference for both new graduates and experienced MIE surgeons alike.
-
4. Robotic-assisted approach for complex cholecystectomies.
PMID:日期:2023-04-11Robotic approaches have facilitated the minimally invasive completion of increasingly complex surgical procedures. In the management of the difficult gallbladder, we have found that the wristed instruments, three-dimensional camera, the ability to use indocyanine green (ICG) with integrated fluorescent imaging, and ease of intracorporeal suturing to be useful in tackling the challenges associated with complex benign gallbladder disease. We describe the rationale and technical lessons learned during four cases of complex cholecystectomies that highlight the management principles and technical advantages afforded by the use of the robotic-assisted laparoscopic (RAL) approach. The cases include a subtotal fundus-first reconstituting cholecystectomy, subtotal fenestrating cholecystectomy, a cholecystocolonic fistula managed by a RAL subtotal fenestrating cholecystectomy, and an iatrogenic cholecystoduodenal fistula managed by RAL cholecystectomy. In each case, the operation was performed safely without intraoperative injury or conversion to open, and three of the four patients were discharged from the recovery room. In our view, these favorable outcomes were greatly facilitated by the robotic platform. It is our intent to share adaptations and innovations that we found helpful to encourage other surgeons with sufficient robotic experience to tackle complex gallbladder cases minimally invasively.